IVIM Technology

📍 Daejeon, South Korea🗓 Founded 2017👥 30 employees💰 Last funded Jan 2024
IntraVital Microscopy is a technique that enables you to directly observe the movement of live cells that make up living tissue in vivo. With this technique, it is possible to distinguish an individual cell among a large number of cells in various organs, which is not possible with conventional biomedical imaging technologies such as MRI or CT, and to track the movement of each cell in three dimensions in real-time. It is also possible to simultaneously image living cells in living organs, surrounding microenvironments, and molecules such as proteins which is impossible with conventional tissue analysis technology. Furthermore, this enables us to analyze the in vivo efficacy of new biopharmaceuticals such as immunological, cell, gene, and antibody therapeutic agents acting in real living organisms at the cellular level which is the basic structural and functional unit of life. The worlds first All-in-One microscopy (IVM) platform developed by IVIM Technology explores the interactions among numerous cells inside the living organisms and will be the next generation high-tech imaging equipment to elucidate the complex processes of human diseases.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded
Investor geography1 country
Korea
1
Frequently asked questions
Who invested in IVIM Technology?
IVIM Technology has 1 investors on record on gritt.io and 1 late-stage investors.
When did IVIM Technology last raise funding?
The most recent investment in IVIM Technology recorded on gritt.io was in January 2024.
When was IVIM Technology founded?
IVIM Technology was founded in 2017.
What industry is IVIM Technology in?
IVIM Technology operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is IVIM Technology based?
IVIM Technology is headquartered in Daejeon, South Korea.